
Time for G7 to Act: Reviving Antibiotics Through Strategic Investment
Antimicrobial resistance is a pressing global health threat, yet the pipeline for new antibiotics remains critically thin. Grace Hampson highlights the dire need for coordinated G7 investment to address this crisis and ensure the development of life-saving drugs.
Read full article




























